{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:39:27Z","timestamp":1786991967013,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jdcr.2023.03.004","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T22:26:57Z","timestamp":1678832817000},"page":"112-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Refractory pityriasis rubra pilaris treated with upadacitinib"],"prefix":"10.1016","volume":"35","author":[{"given":"Eingun James","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam A.","family":"Al-Saedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Bouch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jdcr.2023.03.004_bib1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/jdv.14761","article-title":"Pityriasis rubra pilaris: algorithms for diagnosis and treatment","volume":"32","author":"Roenneberg","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jdcr.2023.03.004_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000381011","article-title":"Ustekinumab as an alternative treatment option for chronic pityriasis rubra pilaris","volume":"7","author":"Chowdhary","year":"2015","journal-title":"Case Rep Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2023.03.004_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaad.2018.03.036","article-title":"Biologics for pityriasis rubra pilaris treatment: a review of the literature","volume":"79","author":"Napolitano","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jdcr.2023.03.004_bib4","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1001\/jamadermatol.2019.2774","article-title":"Treatment of pityriasis rubra pilaris with guselkumab","volume":"155","author":"Pilz","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2023.03.004_bib5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/jamadermatol.2020.0932","article-title":"Evaluation of ixekizumab treatment for patients with pityriasis rubra pilaris: a single-arm trial","volume":"156","author":"Haynes","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2023.03.004_bib6","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaad.2021.04.041","article-title":"Drug survival of systemic and biologic monotherapy treatments for pityriasis rubra pilaris: a retrospective observational study","volume":"86","author":"Kettering","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"13","key":"10.1016\/j.jdcr.2023.03.004_bib7","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa2022516","article-title":"Trial of upadacitinib and adalimumab for psoriatic arthritis","volume":"384","author":"McInnes","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdcr.2023.03.004_bib8","doi-asserted-by":"crossref","unstructured":"Blauvelt A, Teixeira HD, Simpson EL, et\u00a0al. Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: a randomized clinical trial. JAMA Dermatol. 2021;157(9):1047-1055. Published correction appears in JAMA Dermatol. 2022;158(2):219. https:\/\/doi.org\/10.1001\/jamadermatol.2021.3023","DOI":"10.1001\/jamadermatol.2021.3023"},{"issue":"4","key":"10.1016\/j.jdcr.2023.03.004_bib9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamadermatol.2016.5384","article-title":"Interleukin 23-helper T cell 17 axis as a treatment target for pityriasis rubra pilaris","volume":"153","author":"Feldmeyer","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"19","key":"10.1016\/j.jdcr.2023.03.004_bib10","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.3390\/jcm10194307","article-title":"Role of Janus kinase inhibitors in therapy of psoriasis","volume":"10","author":"S\u0142uczanowska-G\u0142\u0105bowska","year":"2021","journal-title":"J Clin Med"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623000917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623000917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:24:54Z","timestamp":1762475094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512623000917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":10,"alternative-id":["S2352512623000917"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.03.004","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refractory pityriasis rubra pilaris treated with upadacitinib","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}